James Investment Research Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XEC
CIMAREX ENERGY CO
XEC
|
+$22.1M |
| 2 |
Southwest Airlines
LUV
|
+$10.7M |
| 3 |
FINL
Finish Line
FINL
|
+$10.2M |
| 4 |
HBI
Hanesbrands
HBI
|
+$9.75M |
| 5 |
MRH
MONTPELIER RE HOLDINGS LTD
MRH
|
+$8.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OA
Orbital ATK, Inc.
OA
|
+$24.2M |
| 2 |
Worthington Enterprises
WOR
|
+$17.6M |
| 3 |
Goldman Sachs
GS
|
+$16.7M |
| 4 |
MAGN
Magnera Corp
MAGN
|
+$14.9M |
| 5 |
Moody's
MCO
|
+$13.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.53% |
| 2 | Financials | 11.34% |
| 3 | Consumer Discretionary | 10.49% |
| 4 | Technology | 7.77% |
| 5 | Energy | 7.44% |
Similar funds
James Investment Research's Q2 2014 Portfolio in Review
As of Q2 2014, James Investment Research held 550 positions worth $3.14B, up 0.59% from $3.13B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
James Investment Research withdrew a net $111M in Q2 2014, closing 44 positions and reducing 145 holdings. Its most notable exit was Magnera Corp, an estimated $14.9M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, James Investment Research opened a new position in Skechers worth $4.53M.
- James Investment Research's largest Q2 2014 buy was Skechers: 297,600 shares worth $4.53M.
- James Investment Research added most to CIMAREX ENERGY CO in Q2 2014, an estimated $22.1M increase.
- James Investment Research's biggest Q2 2014 reduction was Orbital ATK, Inc., cutting an estimated $24.2M.
- James Investment Research fully exited Magnera Corp in Q2 2014, selling an estimated $14.9M.
- James Investment Research's ten largest holdings make up 21% of its $3.14B portfolio in Q2 2014.
- James Investment Research opened 44 new positions and closed 44 in Q2 2014.
- James Investment Research's portfolio value rose 0.59% quarter-over-quarter to $3.14B.
Based on James Investment Research's 13F filing for Q2 2014, filed 22 Jul 2014.